Functional MR imaging as a new paradigm for image guidance

Lia Assumpcao, Michael Choti, Timothy M. Pawlik, Jean Francois Gecshwind, Ihab R. Kamel

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Guidance and monitoring of locoregional minimally invasive treatment for primary or secondary liver tumor are critical to ensuring success and efficacy of therapy. In this article, we review advanced MR imaging techniques, including MR spectroscopy, diffusion and perfusion MR imaging, which can provide essential in vivo physiologic and metabolic information. These innovative imaging techniques can provide potential additional criteria to assess tumor response in addition to the accepted yet often limited Response Evaluation Criteria in Solid Tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria, which are based on decrease of tumor size and lesion enhancement, respectively. In this article, we also discuss the role of tumor size and enhancement in addition to apparent diffusion coefficient (ADC) findings after radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and radioembolization.

Original languageEnglish (US)
Pages (from-to)675-685
Number of pages11
JournalAbdominal Imaging
Volume34
Issue number6
DOIs
StatePublished - Nov 2009

Fingerprint

Neoplasms
Perfusion Imaging
Magnetic Resonance Spectroscopy
Liver
Therapeutics
Response Evaluation Criteria in Solid Tumors

Keywords

  • Alative techniques
  • Chemoembolization
  • Functional MR imaging
  • Liver cancer
  • Palliative therapy
  • Yttrium-90

ASJC Scopus subject areas

  • Gastroenterology
  • Urology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Assumpcao, L., Choti, M., Pawlik, T. M., Gecshwind, J. F., & Kamel, I. R. (2009). Functional MR imaging as a new paradigm for image guidance. Abdominal Imaging, 34(6), 675-685. https://doi.org/10.1007/s00261-008-9481-8

Functional MR imaging as a new paradigm for image guidance. / Assumpcao, Lia; Choti, Michael; Pawlik, Timothy M.; Gecshwind, Jean Francois; Kamel, Ihab R.

In: Abdominal Imaging, Vol. 34, No. 6, 11.2009, p. 675-685.

Research output: Contribution to journalArticle

Assumpcao, L, Choti, M, Pawlik, TM, Gecshwind, JF & Kamel, IR 2009, 'Functional MR imaging as a new paradigm for image guidance', Abdominal Imaging, vol. 34, no. 6, pp. 675-685. https://doi.org/10.1007/s00261-008-9481-8
Assumpcao L, Choti M, Pawlik TM, Gecshwind JF, Kamel IR. Functional MR imaging as a new paradigm for image guidance. Abdominal Imaging. 2009 Nov;34(6):675-685. https://doi.org/10.1007/s00261-008-9481-8
Assumpcao, Lia ; Choti, Michael ; Pawlik, Timothy M. ; Gecshwind, Jean Francois ; Kamel, Ihab R. / Functional MR imaging as a new paradigm for image guidance. In: Abdominal Imaging. 2009 ; Vol. 34, No. 6. pp. 675-685.
@article{ef433dabc6064e81a5be8caa7a0d9df7,
title = "Functional MR imaging as a new paradigm for image guidance",
abstract = "Guidance and monitoring of locoregional minimally invasive treatment for primary or secondary liver tumor are critical to ensuring success and efficacy of therapy. In this article, we review advanced MR imaging techniques, including MR spectroscopy, diffusion and perfusion MR imaging, which can provide essential in vivo physiologic and metabolic information. These innovative imaging techniques can provide potential additional criteria to assess tumor response in addition to the accepted yet often limited Response Evaluation Criteria in Solid Tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria, which are based on decrease of tumor size and lesion enhancement, respectively. In this article, we also discuss the role of tumor size and enhancement in addition to apparent diffusion coefficient (ADC) findings after radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and radioembolization.",
keywords = "Alative techniques, Chemoembolization, Functional MR imaging, Liver cancer, Palliative therapy, Yttrium-90",
author = "Lia Assumpcao and Michael Choti and Pawlik, {Timothy M.} and Gecshwind, {Jean Francois} and Kamel, {Ihab R.}",
year = "2009",
month = "11",
doi = "10.1007/s00261-008-9481-8",
language = "English (US)",
volume = "34",
pages = "675--685",
journal = "Abdominal Imaging",
issn = "0942-8925",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Functional MR imaging as a new paradigm for image guidance

AU - Assumpcao, Lia

AU - Choti, Michael

AU - Pawlik, Timothy M.

AU - Gecshwind, Jean Francois

AU - Kamel, Ihab R.

PY - 2009/11

Y1 - 2009/11

N2 - Guidance and monitoring of locoregional minimally invasive treatment for primary or secondary liver tumor are critical to ensuring success and efficacy of therapy. In this article, we review advanced MR imaging techniques, including MR spectroscopy, diffusion and perfusion MR imaging, which can provide essential in vivo physiologic and metabolic information. These innovative imaging techniques can provide potential additional criteria to assess tumor response in addition to the accepted yet often limited Response Evaluation Criteria in Solid Tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria, which are based on decrease of tumor size and lesion enhancement, respectively. In this article, we also discuss the role of tumor size and enhancement in addition to apparent diffusion coefficient (ADC) findings after radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and radioembolization.

AB - Guidance and monitoring of locoregional minimally invasive treatment for primary or secondary liver tumor are critical to ensuring success and efficacy of therapy. In this article, we review advanced MR imaging techniques, including MR spectroscopy, diffusion and perfusion MR imaging, which can provide essential in vivo physiologic and metabolic information. These innovative imaging techniques can provide potential additional criteria to assess tumor response in addition to the accepted yet often limited Response Evaluation Criteria in Solid Tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria, which are based on decrease of tumor size and lesion enhancement, respectively. In this article, we also discuss the role of tumor size and enhancement in addition to apparent diffusion coefficient (ADC) findings after radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and radioembolization.

KW - Alative techniques

KW - Chemoembolization

KW - Functional MR imaging

KW - Liver cancer

KW - Palliative therapy

KW - Yttrium-90

UR - http://www.scopus.com/inward/record.url?scp=71449117235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71449117235&partnerID=8YFLogxK

U2 - 10.1007/s00261-008-9481-8

DO - 10.1007/s00261-008-9481-8

M3 - Article

C2 - 19048335

AN - SCOPUS:71449117235

VL - 34

SP - 675

EP - 685

JO - Abdominal Imaging

JF - Abdominal Imaging

SN - 0942-8925

IS - 6

ER -